2.57BMarket Cap
LossP/E TTM
Bausch Health Companies Inc
Key Figures
6.000Open
6.915High
22.80MVolume
LossP/E TTM
1.63P/E Dynamic
--Dividend TTM
6.10%Turnover Ratio
6.030Prev. Close
5.980Low
95.09MTurnover
LossP/E Static
-1.45P/B
0.00%Div Yield TTM
-4.81%ROA
11.97052wk High
2.37Volume Ratio
-46.00MNet Profit
373.90MShares
-3.2368EPS TTM
0.42Beta
--ROE
6.06052wk Low
15.51%Amplitude
65.04%Gross Margin
2.57BMarket Cap
8.14Reward/Risk
3.12%Risk Rate
Currency: USD Updated: 2026-07-31 Key Insights
Bausch Health Companies Inc's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 87 out of 155 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 7.17.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Bausch Health Companies Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Bausch Health Companies Inc Highlights
StrengthsRisks
Bausch Health Companies Inc News
More news coming soon, stay tuned...
Earnings Forecast
Strong Buy
Buy
Hold
Sell
Strong Sell
Bausch Health Companies Inc
BHC
6
Indicators
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Bausch Health Companies Inc Info
Bausch Health Companies Inc. is a global, diversified pharmaceutical company. The Salix segment includes sales in the U.S. of GI products. The International segment includes sales of Bausch + Lomb products and Solta Medical aesthetic medical devices, outside the U.S. and Puerto Rico of branded pharmaceutical products, branded generic pharmaceutical products and OTC products. The Solta Medical segment includes global sales of Solta Medical aesthetic medical devices. The Diversified segment includes sales in the U.S. of pharmaceutical products in the areas of neurology and certain other therapeutic classes, dermatology products, generic pharmaceutical products and dentistry products. The Bausch + Lomb segment includes global sales of Bausch + Lomb Vision Care, Surgical and Pharmaceuticals products. Its drug candidate, Larsucosterol binds to and inhibits the activity of DNA methyltransferases, epigenetic enzymes that are elevated and associated with hypermethylation found in AH patients.
Ticker SymbolBHC
CompanyBausch Health Companies Inc
CEOAppio (Thomas J)
Websitehttps://www.bauschhealth.com/
Shareholders
FAQs
What is the current price of Bausch Health Companies Inc (BHC)?
The current price of Bausch Health Companies Inc (BHC) is 6.89.
What is the symbol of Bausch Health Companies Inc?
The ticker symbol of Bausch Health Companies Inc is BHC.
What is the 52-week high of Bausch Health Companies Inc?
The 52-week high of Bausch Health Companies Inc is 11.97.
What is the 52-week low of Bausch Health Companies Inc?
The 52-week low of Bausch Health Companies Inc is 6.06.
What is the market capitalization of Bausch Health Companies Inc?
The market capitalization of Bausch Health Companies Inc is 2.58B.
Is Bausch Health Companies Inc (BHC) currently rated as Buy, Hold, or Sell?
According to analysts, Bausch Health Companies Inc (BHC) has an overall rating of signal_hold, with a price target of 7.17.
What is the Earnings Per Share (EPS TTM) of Bausch Health Companies Inc (BHC)?
The Earnings Per Share (EPS TTM) of Bausch Health Companies Inc (BHC) is 0.42.
